In: Clinical Research in Cardiology, 2015, vol. 104, no. 1, p. 51-58
|
In: Neuroradiology, 2015, vol. 57, no. 10, p. 1045-1054
|
In: European Archives of Oto-Rhino-Laryngology, 2015, vol. 272, no. 7, p. 1651-1658
|
In: The International Journal of Cardiovascular Imaging, 2015, vol. 31, no. 5, p. 915-926
|
In: Clinical Research in Cardiology, 2015, vol. 104, no. 2, p. 124-135
|
In: Annals of Biomedical Engineering, 2015, vol. 43, no. 12, p. 2868-2880
|
In: Cardiovascular Revascularization Medicine, 2019, vol. 20, no. 7, p. 577–582
Background: The advent of bioresorbable vascular scaffolds (BVS) was considered as a potential improvement in percutaneous coronary intervention (PCI) after the groundbreaking development of drug eluting stents (DES). However, the clinical performance, long-term safety and efficacy of BVS in complex coronary lesions remain uncertain. COMPARE ABSORB, a multicenter, single blind, prospective ...
|
In: Annals of Biomedical Engineering, 2014, vol. 42, no. 5, p. 1085-1094
|
In: Seminars in Immunopathology, 2011, vol. 33, no. 3, p. 307-315
|
In: Surveys in Geophysics, 2012, vol. 33, no. 1, p. 169-209
|